Ekta Shirbhate

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Molecular Docking

Top Venues

Mini reviews in medicinal chemistry

Current topics in medicinal chemistry

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Ekta Shirbhate, Vaibhav Singh, Rakesh Kore, Subham Vishwakarma, Ravichandran Veerasamy, Amit K Tiwari, Harish Rajak
The Role of Cytokines in Activation of Tumour-promoting Pathways and Emergence of Cancer Drug Resistance. Current topics in medicinal chemistry 24 (6) (2024)
Ekta Shirbhate, Vaibhav Singh, Rakesh Kore, Subham Vishwakarma, Ravichandran Veerasamy, Amit K Tiwari, Harish Rajak
The Role of Cytokines in Activation of Tumour-promoting Pathways and Emergence of Cancer Drug Resistance. Current topics in medicinal chemistry (2024)
Ekta Shirbhate, Vaibhav Singh, Aditya Mishra, Varsha Jahoriya, Ravichandran Veerasamy, Amit K Tiwari, Harish Rajak
Targeting Lysosomes: A Strategy Against Chemoresistance in Cancer. Mini reviews in medicinal chemistry (2024)
Ekta Shirbhate, Vaibhav Singh, Rakesh Kore, Subham Vishwakarma, Ravichandran Veerasamy, Amit K Tiwari, Harish Rajak
The Role of Cytokines in Activation of Tumour-promoting Pathways and Emergence of Cancer Drug Resistance. Current topics in medicinal chemistry 24 (6) (2024)
Ekta Shirbhate, Vaibhav Singh, Aditya Mishra, Varsha Jahoriya, Ravichandran Veerasamy, Amit K Tiwari, Harish Rajak
Targeting Lysosomes: A Strategy Against Chemoresistance in Cancer. Mini reviews in medicinal chemistry 24 (15) (2024)
Vijay K Patel, Aayush Vaishnaw, Ekta Shirbhate, Rakesh Kore, Vaibhav Singh, Ravichandran Veerasamy, Harish Rajak
Cortisol as a Target for Treating Mental Disorders: A Promising Avenue for Therapy. Mini reviews in medicinal chemistry (2023)
Ekta Shirbhate, Preeti Patel, Vijay K Patel, Ravichandran Veerasamy, Prabodh Chander Sharma, Harish Rajak
The combination of histone deacetylase inhibitors and radiotherapy: a promising novel approach for cancer treatment. Future oncology (London, England) 16 (30) (2020)